Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Burden of Beta-Thalassemia - Quality of Life and Health Care Resource Utilization- A Prospective Observational Study

NCT02626689 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02626689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02626689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Burden of Beta-Thalassemia - Quality of Life and Health Care Resource Utilization- A Prospective Observational Study
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
March 1, 2016
Completion date
January 3, 2017
Enrollment
100 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

beta-thalassemia